<DOC>
	<DOCNO>NCT01106066</DOCNO>
	<brief_summary>To evaluate efficacy preoperative S-1/oxaliplatin/RT locally advance gastric cancer</brief_summary>
	<brief_title>Phase I/II Study Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin Patients With Gastric Cancer : Randomized Phase II Study S-1/RT vs. S-1/Oxaliplatin/RT</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients older 18 year Patients localize , histologically confirm gastric gastroesophageal adenocarcinoma ③ Localized gastric cancer clinical stage ( T2N ( + ) , T3/T4 ) ECOG performance status 0 1 ⑤ Adequate organ function evidence follow ; Absolute neutrophil count &gt; 1.5 x 109/L ; platelet &gt; 100 x 109/L ; total bilirubin ≤1.5 UNL ; AST and/or ALT &lt; 5 UNL ; creatinine clearance ≥ 50mL/min ⑥ Written informed consent form T1 ( regardless N stage ) , T2N0 M1 ③ Peritoneal seed ④ Uncontrolled medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>